Caffeine, creatine, GRIN2A and Parkinson's disease progression.

about

The emerging science of precision medicine and pharmacogenomics for Parkinson's disease.Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's disease.Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy.

P2860

Q38369889-6E069F4C-9AA1-4C0E-82AF-6173CDD68FEB Q47664707-F0FD3466-EC8E-4470-82BF-7D9C77BA644B Q55266660-2BCBF232-AB3C-4221-A04F-A0DF7EB503AC

P2860

Caffeine, creatine, GRIN2A and Parkinson's disease progression.

Item

http://www.wikidata.org/entity/Q38893103

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Caffeine, creatine, GRIN2A and Parkinson's disease progression.

@en

type

Item

label

Caffeine, creatine, GRIN2A and Parkinson's disease progression.

@en

prefLabel

Caffeine, creatine, GRIN2A and Parkinson's disease progression.

@en

P1476

Caffeine, creatine, GRIN2A and Parkinson's disease progression.

@en

P2093

Anne-Marie Wills

http://www.w3.org/2001/XMLSchema#string

Barbara C Tilley

http://www.w3.org/2001/XMLSchema#string

Cai Wu

http://www.w3.org/2001/XMLSchema#string

Carlos Singer

http://www.w3.org/2001/XMLSchema#string

Daniel Truong

http://www.w3.org/2001/XMLSchema#string

David K Simon

http://www.w3.org/2001/XMLSchema#string

Haydeh Payami

http://www.w3.org/2001/XMLSchema#string

Jacquelyn Bainbridge

http://www.w3.org/2001/XMLSchema#string

Jay S Schneider

http://www.w3.org/2001/XMLSchema#string

Katja Lohmann

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee

Caffeine interaction with glutamate receptor gene GRIN2A: Parkinson's disease in Swedish population

A global reference for human genetic variation

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.

Caffeine and progression of Parkinson disease

Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration

Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies.

Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.

Lack of replication of the GRIN2A-by-coffee interaction in Parkinson disease.

Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's disease.

P304

355-359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JNS.2017.02.032

http://www.w3.org/2001/XMLSchema#string

P478

375

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28320167

http://www.w3.org/2001/XMLSchema#string

P932

5386398

http://www.w3.org/2001/XMLSchema#string

Caffeine, creatine, GRIN2A and Parkinson's disease progression.

about

P2860

P2860

Caffeine, creatine, GRIN2A and Parkinson's disease progression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932